LATEST

HOW IT DEVELOPED

1. Personalized mRNA vaccine for melanoma cut risk of cancer’s return in late-stage trial nbcnews.com  ·  23.10 20:42
2. ‘Bespoke’ mRNA vaccine significantly reduces risk of melanoma recurrence or death, clinical trial shows theguardian.com  ·  23.10 06:27
3. A Personalized Cancer Vaccine Lowers Melanoma Recurrence by 42% time.com  ·  23.10 01:54
4. Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42% arstechnica.com  ·  23.10 00:12
5. Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna Report nytimes.com  ·  22.10 22:01

More in this section

Other stories